When someone walks into an emergency room with symptoms of a stroke, every second matters. But today, diagnosing the type of ...
A/B testing, once heralded as the gold standard for data-driven decision-making, often slows companies down due to an ...
Hologic’s HOLX acquisition of Biotheranostics in 2021 accelerated its entry into a large, fast-growing oncology adjacency. The business also carries higher margins than the company’s legacy service ...
From the early use of radioiodine to the expanding reach of prostate-specific membrane antigen and somatostatin receptor ...